NRX Pharmaceuticals, Inc NT 10-K, filed Apr 1, 2021
NRX Pharmaceuticals, Inc. (NRXP)
NT 10-K
2021-04-01
For: 2020-12-31
View Original
Added on
October 18, 2026
|
|
|
|
OMB APPROVAL
|
|
|
|
|
OMB Number:
3235-0058
|
|
|
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
|
Expires:
February 28, 2022
|
|
|
Estimated
average burden
|
|||
|
|
|
|
hours per
response.......2.50
|
|
|
|
|
|
|
|
FORM
12b-25
|
SEC FILE NUMBER
|
|
|
|
001-38302
|
||
|
|
|
|
|
|
|
|
|
CUSIP NUMBER
|
|
|
NOTIFICATION
OF LATE FILING
|
089482-103
|
|
|
(Check one):
|
☑
|
Form
10-K
|
☐
|
Form
20-F
|
☐
|
Form
11-K
|
☐
|
Form
10-Q
|
☐
|
Form
10-D
|
☐
|
Form
N-CEN
|
☐
|
Form
N-CSR
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For Period Ended:
December
31, 2020
|
|||||||||||
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
||||||||||
|
|
☐
|
Transition
Report on Form 10-K
|
||||||||||||
|
|
|
|
|
|
||||||||||
|
|
☐
|
Transition
Report on Form 20-F
|
||||||||||||
|
|
|
|
|
|
||||||||||
|
|
☐
|
Transition
Report on Form 11-K
|
||||||||||||
|
|
|
|
|
|
||||||||||
|
|
☐
|
Transition
Report on Form 10-Q
|
||||||||||||
|
|
|
|
|
|
||||||||||
|
|
☐
|
Transition
Report on Form N-SAR
|
||||||||||||
|
|
|
|
|
|
||||||||||
|
|
|
|
For the Transition Period Ended:
__________________
|
|||||||||||
|
|
|
|||||||||||||
|
Read Instructions (on back page) Before Preparing Form. Please
Print or Type.
Nothing in this form shall be construed to imply that the
Commission has verified any information contained
herein.
|
If the
notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:
N/A
PART I – REGISTRANT INFORMATION
Big Rock Partners Acquisition Corp.
Full
Name of Registrant
N/A
Former
Name if Applicable
2645 N. Federal Highway, Suite 230
Address of Principal Executive Office (Street and
Number)
Delray Beach, FL 33483
City,
State and Zip Code
PART II – RULES 12b-25 (b) AND (c)
If the
subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b),
the following should be completed. (Check box if
appropriate)
|
☒
|
(a)
The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or
expense;
(b)
The subject annual report, semi-annual report, transition report on
Form 10-K, Form 20-F, Form 11-K, Form N-CENR or Form-CSR, or
portion thereof, will be filed on or before the fifteenth calendar
day following the prescribed due date; or the subject quarterly
report or transition report on Form 10-Q or subject distribution
report on Form 10-D, or portion thereof, will be filed on or before
the fifth calendar day following the prescribed due date;
and
(c)
The accountant’s statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
|
PART III – NARRATIVE
State
below in reasonable detail the reasons why the Forms 10-K, 20-F,
11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion
thereof, could not be filed within the prescribed time period.
(Attach extra sheets if needed)
Big
Rock Partners Acquisition Corp. (the “Company”) has
determined that it is unable, without unreasonable effort or
expense, to file its Annual Report on Form 10-K for the year ended
December 31, 2020 (“Form 10-K”) by the prescribed due
date. The Company requires additional time to compile and verify
the data required to be included in the Form 10-K. The Company
expects to file the Form 10-K within the additional time
allowed.
PART IV – OTHER INFORMATION
|
(1)
|
Name
and telephone number of person to contact in regard to this
notification
|
||
|
|
Richard Ackerman
(Name)
|
(310)
(Area
Code)
|
734-2300
(Telephone
Number)
|
|
|
|
||
|
(2)
|
Have
all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such
shorter period that the registrant was required to file such
report(s) been filed? If answer is no, identify
report(s).
|
☒ Yes ☐ No
|
|
|
|
|
||
|
(3)
|
Is it
anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject
report or portion thereof?
|
☐ Yes ☒ No
|
|
|
|
|
||
|
|
If so,
attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
|
||
2
|
|
BIG
ROCK PARTNERS ACQUISITION CORP.
|
|
||
|
(Name of Registrant
as Specified in Charter)
|
||||
|
|
||||
|
has caused this
notification to be signed on its behalf by the undersigned hereunto
duly authorized.
|
||||
|
|
||||
|
Date: April 1, 2021
|
|
|
By:
|
/s/ Richard
Ackerman
|
|
|
|
|
|
Richard Ackerman,
Chairman, President and Chief Executive Officer
|
|
|
|
|||
INSTRUCTION:
The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of
the person signing the form shall be typed or printed beneath the
signature. If the statement is signed on behalf of the registrant
by an authorized representative (other than an executive officer),
evidence of the representative’s authority to sign on behalf
of the registrant shall be filed with the form.
|
ATTENTION
Intentional misstatements or omissions of fact constitute Federal
Criminal Violations (See 18 U.S.C. 1001).
|
3